Addressing Gaps for Women With HIV Involved in the Criminal Justice System

Jaimie P. Meyer, MD, from the Yale School of Medicine, discusses her work on identifying opportunities to reduce risk for HIV transmission, particularly in women ...

Treating and Preventing HIV With Generic Drugs

Generic antiretroviral agents have had a dramatic effect on outcomes in developing nations, and their availability in developed countries is rapidly expanding as more brand-name ...

Treating Major Depressive Disorder Improves Outcomes in HIV

Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.

Improving Adherence to ART in HIV

The rapidly developing landscape of antiretroviral therapy adherence monitoring has great potential for clinical application, but cost-effectiveness and feasibility studies are needed to define the ...

Preventing HIV, STIs Through School-Based Programs

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based ...

PrEP Crucial for People Involved in Criminal Justice Systems

Important strategies to consider for people involved in the criminal justice systems include linkage to antiretroviral therapy for those who are HIV positive and linkage ...

Pausing ART: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively ...
HIV/AIDS

Latest News

Risk Prediction Scores Aid Management of Chronic Kidney Disease in HIV

Risk Prediction Scores Aid Management of Chronic Kidney Disease in HIV

Investigators sought to assess the effectiveness of tools to predict the risk of chronic kidney disease in individuals with HIV.

Assessment of Chronic Opioid Therapy in People Living With HIV

Assessment of Chronic Opioid Therapy in People Living With HIV

Appropriate monitoring and implementation of guidelines for opioid therapy is lacking in patients living with HIV.

Multilevel Interventions Needed to Improve Barriers to PrEP

Multilevel Interventions Needed to Improve Barriers to PrEP

The final review included 47 articles that fell under 1 of the following categories: primary data on cognitive variables of providers; data on cognitive variables and perspectives of individuals at risk for HIV infection; literature on PrEP implementation; and case studies of PrEP demonstration and implementation projects.

Higher Rate of Mother-to-Child Transmission Among Women With Perinatal HIV

Higher Rate of Mother-to-Child Transmission Among Women With Perinatal HIV

Although rates of mother-to-child transmission of HIV have decreased as a result of effective treatments and protective delivery and feeding practices, transmission does persist.

Social Network Support Decreases Risk for HIV Seroconversion in Black MSM

Social Network Support Decreases Risk for HIV Seroconversion in Black MSM

The increased presence of social network support may decrease the risk for HIV seroconversion in black MSM.

Long-Term Viral Suppression May Decrease Cancer Risk in HIV+ Individuals

Long-Term Viral Suppression May Decrease Cancer Risk in HIV+ Individuals

Antiretroviral therapy resulting in long-term viral suppression of HIV may contribute to cancer prevention.

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

Simplification to atazanavir/ritonavir plus lamivudine as a maintenance therapy has the same effect on markers of systemic inflammation biomarkers as triple therapy.

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

The maximum concentration of the integrase inhibitor dolutegravir was significantly higher in older people living with HIV.

Prezcobix Not Recommended During Pregnancy, According to Updated Labeling

Prezcobix Not Recommended During Pregnancy, According to Updated Labeling

The labeling now states that Prezcobix is not recommended for use in pregnant women due to substantially lower exposures of the active ingredients, darunavir and cobicistat, during pregnancy.

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

An increased risk for cardiovascular disease with ritonavir-boosted darunavir regimens for HIV was identified in a prospective multicenter study.

Feature Article

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Mental health professionals supporting patients living with HIV need to make space for their patients to process the emotional effect of their diagnosis, but not to make assumptions about what it means to them.

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

How HIV Affects Cervical Cancer Risk and Outcomes

How HIV Affects Cervical Cancer Risk and Outcomes

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

Role of the Microbiome on HIV Infection, Prevention, and Treatment

Role of the Microbiome on HIV Infection, Prevention, and Treatment

The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future interventions.

Adolescents at Risk for HIV Should Be Offered PrEP

Adolescents at Risk for HIV Should Be Offered PrEP

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Why Patients Discontinue ART— and What You Can Do to Stop It

Why Patients Discontinue ART— and What You Can Do to Stop It

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective strategy for preventing bone loss seen in HIV-infected individuals.

Aging With HIV: Expert Insights on Complications and Challenges

Aging With HIV: Expert Insights on Complications and Challenges

Three HIV experts provide their insights into aging-related challenges and complications faced by people living with HIV.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS